Compound ID | 87
Class: Celecoxib-derived antibacterial inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Salmonella enterica serovar Typhimurium. Has also been shown to be an anti-mycobacterial agent (against Mycobacterium abscessus) |
Propensity to select resistant mutants: | Yes |
Institute where first reported: | Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan |
Year first mentioned: | 2009 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|